Telemedicine and Diabetic Retinopathy: Review of Published Screening Programs
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Diabetic Retinopathy (DR) is a leading cause of blindness worldwide even though successful treatments exist. Improving screening and treatment could avoid many cases of vision loss. However, due to an increasing prevalence of diabetes, traditional in-person screening for DR for every diabetic patient is not feasible. Telemedicine is one viable solution to provide high-quality and efficient screening to large number of diabetic patients. PURPOSE: To provide a narrative review of large DR telemedicine screening programs. METHODS: Articles were identified through a comprehensive search of the English-language literature published between 2000 and 2014. Telemedicine screening programs were included for review if they had published data on at least 150 patients and had available validation studies supporting their model. Screening programs were then categorized according to their American Telemedicine Association Validation Level. RESULTS: Seven programs from the US and abroad were identified and included in the review. Three programs were Category 1 programs (Ophdiat, EyePacs, and Digiscope), two were Category 2 programs (Eye Check, NHS Diabetic Eye Screening Program), and two were Category 3 programs (Joslin Vision Network, Alberta Screening Program). No program was identified that claimed category 4 status. Programs ranged from community or city level programs to large nationwide programs including millions of individuals. The programs demonstrated a high level of clinical accuracy in screening for DR. There was no consensus amongst the programs regarding the need for dilation, need for stereoscopic images, or the level of training for approved image graders. CONCLUSION: Telemedicine programs have been clinically validated and successfully implemented across the globe. They can provide a high-level of clinical accuracy for screening for DR while improving patient access in a cost-effective and scalable manner.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
EyePACS: An Adaptable Telemedicine System for Diabetic Retinopathy Screening
Cuadros, J., & Bresnick, G. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300315 · Cited by 390 · cited 1×
“If an outside grader was used, the grader had to undergo EyePACS certification [15].”
MethodVijan, S. (2000) · JAMA · doi:10.1001/jama.283.7.889 · Cited by 295
Longitudinal rates of annual eye examinations of persons with diabetes and chronic eye diseases
Lee, P. P., Feldman, Z. W., Ostermann, J., Brown, D. S., & Sloan, F. A. (2003) · Ophthalmology · doi:10.1016/s0161-6420(03)00817-0 · Cited by 184 · cited 1×
“However, according to the National Committee for Quality Assurance, our current health care system meets guidelines for diabetic screening only by 40-60% of the time [3,4].”
MethodMydriasis and glaucoma: exploding the myth. A systematic review
Pandit, R. J., & Taylor, R. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00368.x · Cited by 94 · cited 2×
“When longer acting agents were used, such a phenylephrine, rates of angle closure were between 1 in 3,380 to 1 in 20, 000 depending on the population and study methods [49].”
Background
Cited by
Digital technology, tele-medicine and artificial intelligence in ophthalmology: A global perspective
Li, J.-P. O., Liu, H., Ting, D. S. J., Jeon, S., Chan, R. V. P., Kim, J. E., Sim, D. A., Thomas, P. B. M., Lin, H., Chen, Y., et al. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100900 · Cited by 626
Virtual Ophthalmology: Telemedicine in a COVID-19 Era
Saleem, S. M., Pasquale, L. R., Sidoti, P. A., & Tsai, J. C. (2020) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2020.04.029 · Cited by 291
Evaluation of Artificial Intelligence–Based Grading of Diabetic Retinopathy in Primary Care
Kanagasingam, Y., Xiao, D., Vignarajan, J., Preetham, A., Tay-Kearney, M.-L., & Mehrotra, A. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.2665 · Cited by 185
A data-driven approach to referable diabetic retinopathy detection
Pires, R., Avila, S., Wainer, J., Valle, E., Abramoff, M. D., & Rocha, A. (2019) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2019.03.009 · Cited by 164
Joseph, S., Kim, R., Ravindran, R. D., Fletcher, A. E., & Ravilla, T. D. (2019) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2019.1070 · Cited by 34
Metadata
- Authors
- Newman Casey, P. A.
- Venue
- Journal of Endocrinology and Diabetes
- Publisher
- Symbiosis Group
- Published
- 2015-10-11
- Volume
- 2
- Issue
- 4
- Pages
- 01-10
- ISSN
- 2374-6890 (ISSN-L)
- OpenAlex
- W2406935203
- Cited by
- 57
- References
- 4
- FWCI
- 2.96
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Telemedicine and Diabetic Retinopathy: Review of Published Screening Programs. https://app.cochat.ai/papers/10.15226/2374-6890/2/4/00131
- The paper
- Newman Casey, P. A. (2015). Telemedicine and Diabetic Retinopathy: Review of Published Screening Programs. Journal of Endocrinology and Diabetes. https://doi.org/10.15226/2374-6890/2/4/00131
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.